SCHRIESHEIM ROBERT A

Director Schriesheim buys 42,098 shares of ALIT at $2.38; stock down 70.6% from 52-week high, company unprofitable with -31.6% revenue decline.

Robert A. Schriesheim (Director) purchased 42,098 shares at $2.38 on 2025-11-26, increasing his holdings by 62.8% to 109,130 shares total. This open-market buy occurs in a materially deteriorating context: Alight is unprofitable with a -$1.1B net loss over its most recent full fiscal year, revenue declined 31.6% year-over-year, and the stock trades at $2.36 (70.6% below its 52-week high of $8.02). Within the same 14-day window, 3 other insiders also purchased shares, forming a cluster buy pattern. However, Schriesheim's own purchase history at this ticker shows no pattern of well-timed buys: his 2 prior trades at ALIT (June 2025 and March 2025) both resulted in losses within the 90-day window, with neither well-timed at the 90-day mark. The stock has also fallen 18.1% in the past 30 days and 40.0% over 90 days, continuing the downward momentum.

Director Robert Schriesheim bought 216 ALIT shares at $5.26; stock down -11.3% in 90 days, mirrors his prior ALIT purchase pattern.

Director Robert A Schriesheim purchased 216 shares of Alight Inc at $5.26 on 2025-06-16, adding to his 33.2K share holdings. His prior purchase at ALIT on 2025-03-03 underperformed, with a 90-day return of -19.6%, and the current trade at $5.26 is already down -11.3% over the past 90 days. Fundamentally, the company remains unprofitable with annual revenue declining -31.6% year-over-year and net income of -$25.0M in the latest quarter. The timing and fundamentals context suggest this repurchase occurs in a challenged operational and valuation environment.

Director Schriesheim buys 22,092 shares of ALIT at $6.79; stock down 38.9% from 52-week high, company posted -$74.0M net loss

Director Robert A. Schriesheim purchased 22,092 shares at $6.79 on March 3, 2025, his first open-market position in ALIT. The purchase occurs against a deteriorating backdrop: the stock trades at -38.9% from its 52-week high of $10.32, revenue contracted 31.6% year-over-year to $555.0M, and the company reported a net loss of -$74.0M for its most recent full fiscal year. Schriesheim's cross-ticker insider track record shows modest predictive power (1 prior sale with 0% well-timed rate), offering limited evidence of timing acumen. The transaction's modest significance reflects the stock's distressed valuation context and the absence of corroborating insider activity or material company catalysts in the filing.